Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

A bstract Behavioral science offers several ideas about what it takes to get people to
vaccinate. Colleagues and I previously reviewed the evidence for these propositions and put …

Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …

Importance In the US, safety concern has been identified as a primary barrier to initiating the
human papillomavirus (HPV) vaccine. It is unclear if the public's sentiment concerning HPV …

Background Mortality rates from cervical cancer demonstrate deep inequality in health
between richer and poorer populations. Over 310 000 women died of this preventable …

Background Human papillomavirus (HPV) vaccine uptake among US adolescents is
primarily dependent on the intent of their parents. To the best of our knowledge, an analysis …

Background Vaccine hesitancy is a growing threat to national and global health security.
The current study was undertaken to provide insights into the global scientific literature on …

Objective To evaluate whether the social media strategy developed for the campaign Stop
HPV–stop cervical cancer was successful at engaging target groups in communication …